HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hitoshi Funahashi Selected Research

Integrin alpha6

6/2007Gastrointestinal stromal tumor of the rectum with liver metastasis: report of a case.
2/2007Expression of alpha6 integrin subunit is associated with malignancy in gastric gastrointestinal stromal tumors.
2/2006Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
11/2005Anaplastic carcinoma of the pancreas with squamous features: report of a case and immunohistochemical study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hitoshi Funahashi Research Topics

Disease

29Neoplasms (Cancer)
04/2014 - 01/2003
27Pancreatic Neoplasms (Pancreatic Cancer)
04/2014 - 01/2003
14Neoplasm Metastasis (Metastasis)
04/2014 - 11/2002
4Adenocarcinoma
09/2006 - 01/2003
3Stomach Neoplasms (Stomach Cancer)
09/2010 - 07/2007
3Colorectal Neoplasms (Colorectal Cancer)
06/2008 - 07/2007
2Colonic Neoplasms (Colon Cancer)
05/2009 - 03/2005
2Carcinogenesis
02/2009 - 08/2008
2Rectal Neoplasms (Rectal Cancer)
06/2008 - 03/2005
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
02/2007 - 10/2006
2Carcinoma (Carcinomatosis)
11/2005 - 11/2002
1Inflammation (Inflammations)
03/2021
1Small Cell Carcinoma
10/2013
1Foreign Bodies (Foreign Body)
06/2011
1Cardiac Tamponade
05/2011
1Inguinal Hernia (Direct Inguinal Hernia)
04/2010
1Lymphatic Metastasis
05/2007
1Hematologic Neoplasms (Hematological Malignancy)
10/2006
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2006
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2006

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
05/2010 - 01/2003
14IntegrinsIBA
01/2008 - 01/2003
9InterleukinsIBA
10/2010 - 01/2003
8EnzymesIBA
08/2008 - 01/2003
8ImmunosorbentsIBA
08/2008 - 01/2003
6Interleukin-1alpha (Interleukin 1 alpha)IBA
05/2009 - 01/2003
6Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
07/2007 - 08/2003
5Proliferating Cell Nuclear Antigen (PCNA)IBA
06/2007 - 01/2004
5Interleukin-1 Type I ReceptorsIBA
06/2007 - 07/2003
4Biological ProductsIBA
04/2014 - 03/2005
4Messenger RNA (mRNA)IBA
05/2010 - 10/2006
4NF-kappa B (NF-kB)IBA
04/2010 - 07/2004
4LigandsIBA
07/2007 - 01/2003
4Integrin alpha6IBA
06/2007 - 11/2005
3Interleukin-8 (Interleukin 8)IBA
04/2010 - 04/2004
3Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
08/2008 - 01/2003
3Laminin (Merosin)IBA
01/2008 - 01/2003
3Indicators and Reagents (Reagents)IBA
03/2006 - 07/2003
2Small Interfering RNA (siRNA)IBA
05/2010 - 10/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2010 - 08/2008
2Dinoprostone (PGE2)FDA Link
08/2008 - 05/2008
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2008 - 08/2007
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
08/2008 - 05/2008
2S100 Proteins (S 100 Protein)IBA
01/2008 - 11/2005
2Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
10/2007 - 07/2007
2Gabexate (Foy)IBA
10/2007 - 07/2007
2Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
09/2007 - 10/2006
2Stem Cell FactorIBA
09/2007 - 10/2006
2Integrin alpha5beta1IBA
02/2007 - 01/2004
2CarbohydratesIBA
09/2006 - 03/2005
2AntigensIBA
09/2006 - 03/2005
2Integrin beta1IBA
02/2006 - 10/2005
2thiazolyl blueIBA
07/2004 - 04/2004
1Angiogenesis InhibitorsIBA
04/2014
1zerumboneIBA
04/2014
1Irinotecan (Camptosar)FDA LinkGeneric
10/2013
1Chromogranin AIBA
10/2013
1Cisplatin (Platino)FDA LinkGeneric
10/2013
1SynaptophysinIBA
10/2013
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2010
1Insulin-Like Growth Factor I (IGF-1)IBA
05/2010
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
05/2010
1Proteasome InhibitorsIBA
04/2010
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
04/2010
1ChemokinesIBA
02/2009
1matrigelIBA
02/2009
1Chemokine CXCL12IBA
02/2009
1Prostaglandin-E SynthasesIBA
08/2008
1Phospholipases A2 (Phospholipase A2)IBA
08/2008
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2008
1Monoclonal AntibodiesIBA
06/2008
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
05/2008
1Fish OilsIBA
05/2008
1prostaglandin E3 (PGE3)IBA
05/2008
1Arachidonic Acid (Vitamin F)IBA
05/2008
1Fibronectins (Fibronectin)IBA
01/2008
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2008
1DesminIBA
01/2008
1CollagenIBA
01/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2007
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
08/2007
1nimesulide (Aulin)IBA
08/2007
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2007
1Paclitaxel (Taxol)FDA LinkGeneric
07/2007
1Peptide Hydrolases (Proteases)FDA Link
07/2007
1Protease Inhibitors (Protease Inhibitor)IBA
07/2007
1Vascular Endothelial Growth Factor CIBA
05/2007
1Imatinib Mesylate (Gleevec)FDA Link
10/2006
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2006

Therapy/Procedure

6Therapeutics
09/2010 - 10/2004
4Drug Therapy (Chemotherapy)
10/2013 - 11/2002
2Colectomy
09/2006 - 01/2006
1Cholecystectomy
03/2021
1Combination Drug Therapy (Combination Chemotherapy)
10/2013
1Surgical Instruments (Clip)
06/2011
1Minimally Invasive Surgical Procedures
06/2011
1Central Venous Catheters
05/2011
1Prostheses and Implants (Prosthesis)
04/2010
1Splenectomy
07/2007
1Gastrectomy
07/2007